APPLICATION OF COMBINED DRUG OF RECOMBINANT FOLLICULE-STIMULATING HORMONE/LUTEINIZING HORMONE IN PROGRAMS OF ASSISTED REPRODUCTIVE TECHNOLOGIES
Infertility treatment using assisted reproductive technologies in the majority of cases involving the use of various ovarian stimulation protocols to obtain the optimal number of oocytes and embryos.The use of analogues of gonadotropin-releasing hormone in ART programs prevents the synthesis of endo...
Main Authors: | A. G. Syrkasheva, E. O. Ibragimova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2016-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1436 |
Similar Items
-
Is there a Need for Luteinizing Hormone (LH) Estimation in Patients Undergoing Ovarian Stimulation with Gonadotropin-Releasing Hormone (GnRH) Antagonists and Recombinant Follicle-Stimulating Hormone (rFSH)?
by: Amar Ramachandran, et al.
Published: (2014-01-01) -
Effects of Luteinizing Hormone Supplementation on Ovarian Response and Assisted Reproductive Technology Outcomes in Antagonist In vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: A Meta-analysis
by: Lei Chen, et al.
Published: (2019-01-01) -
Advances in the Regulation of Mammalian Follicle-Stimulating Hormone Secretion
by: Hao-Qi Wang, et al.
Published: (2021-04-01) -
A novel orally active gonadotropin‐releasing hormone antagonist, relugolix, is a potential substitute for injectable GnRH antagonists in controlled ovarian stimulation in assisted reproductive technology
by: Michiko Hamada, et al.
Published: (2022-01-01) -
Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty
by: Stefanie Schubert, et al.
Published: (2021-06-01)